Hypertension Clinical Trial
Official title:
An Enhanced Medication Monitoring Program
The goal of the Enhanced Medication Management Program (eMMp) being developed by MedMinder
Systems, Inc. is to increase the ability of frail elders to adhere to complex medication
regimens for chronic conditions. Adherence will facilitate effective self-care and decrease
personal and societal costs associated with disease progression and loss of independence.
Multiple studies have shown that more frequent personal follow-up is the most effective way
to maximize medication adherence, but such personal care is too costly to translate well to
real life in a world of limited healthcare resources.
Currently available "smart pillboxes" are too expensive, too limited in the number and types
of medications delivered, and too technically complex for the large majority of senior
citizens. The eMMp is designed to deliver prompts and reminders to the user, to be remotely
programmable by caregivers, to allow the option of using pre-filled medication trays, to
provide electronic adherence reports to family/caregivers and to provide personalized
reinforcing phone calls from professional caregivers, all at a modest cost. The in-home
ReMinder will use a familiar pillbox layout (4 doses/day for 7 days) and allow easy removal
of medication cups by elderly, rheumatic fingers. Installation will require only an
electrical outlet (no modems or dedicated phone lines). Once plugged in, the built-in pager
will continuously download remotely programmed visual and/or aural prompts and reminders
from a central server (RemoteMind). It will continuously upload the date and time when each
medi-cation cup is removed and when weekly refill is carried out, enabling remote adherence
monitoring, alerts to caregivers, and follow-up intervention(s) from personal and/or
professional caregivers as needed.
The hypothesis to be tested in this 2 year SBIR Phase I work plan is that the eMMp will
significantly im-prove adherence and clinical outcome (blood pressure control) in a
population of frail elderly who are hyper-tensive. SBIR Phase II will determine the minimum
level of intervention needed to achieve sustained medication adherence and control of blood
pressure in a larger group of hypertensive elders.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |